{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'COORDINATING INVESTIGATOR AGREEMENT', 'Original Protocol Dated 26 February 2016', 'Amendment 05 Dated 25 March 2019', 'IND number: 127692; EudraCT number: 2016-000630-22', 'Article 45 or 46 of 1901/2006 does not apply', 'A Randomized, Double-blind, Placebo-controlled Study of TEV-50717 (Deutetrabenazine)', 'for the Treatment of Tourette Syndrome in Children and Adolescents', 'I have read the protocol with amendment 05 and agree that it contains all necessary details for', 'carrying out this study. I am qualified by education, experience, and training to conduct this', 'clinical research study. The signature below constitutes agreement with this protocol and', 'attachments, and provides assurance that this study will be conducted according to all', 'stipulations of the protocol, including all statements regarding confidentiality, and according to', 'national and local legal and regulatory requirements and applicable regulations and guidelines.', 'I will make available the protocol and all information on the investigational medicinal product', '(IMP) that were furnished to me by the sponsor to all physicians and other study personnel', 'reporting to me who participate in this study and will discuss this material with them to ensure', 'that they are fully informed regarding the IMP and the conduct of the study. I agree to keep', 'records on patient information, IMPs shipment and return forms, and other information collected', 'during the study, in accordance with my responsibilities under the function of the coordinating', 'investigator and in accordance with national and local GCP regulations as well as all other', 'national and international laws and regulations. In addition I will assume the responsibility of the', 'coordinating investigator according to a separate contract.', 'Coordinating Investigator', 'Title:', 'Address of Investigational Center:', 'Tel:', 'Coordinating Investigator', 'Signaturi', 'Date', '3/25/19', '6']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'LABORATORY AND OTHER DEPARTMENTS AND INSTITUTIONS', 'Central Institutional Review Board', 'Copernicus Group IRB', '1 Triangle Drive', 'Durham, NC 27709', 'USA', 'Central Clinical Laboratory', 'Q2 Solutions (Quest) LLC', '27027 Tourney Road, Suite 2E', 'Valencia, CA 91355', 'USA', 'Electronic Data Capture', 'Medidata RAVE (through Syneos Health)', 'Contract Research Organization; Safety and Efficacy Data Analysis', 'Syneos Health, LLC', '1030 Sync Street', 'Morrisville, NC 27560', 'USA', 'Central Electrocardiogram Evaluation', 'ERT', '1818 Market Street 10th Floor', 'Philadelphia, PA 19103', 'USA', 'Integrated Response Technology', 'Endpoint', '55 Francisco Street, Suite 200', 'San Francisco, CA 94133', 'USA', 'ePRO, eCOA, and Scales Training', 'Bracket Global, LLC', '575 East Swedesford Road, Suite 200', 'Wayne, PA 19087', 'USA', '7']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'CLINICAL STUDY PERSONNEL CONTACT INFORMATION', \"Sponsor's Authorized Representative:\", 'Teva Branded Pharmaceutical Products R&D, Inc.', 'Legal Representative of the Sponsor in the EU', 'For medical issues, contact the physician listed below:', '8']\n\n###\n\n", "completion": "END"}